--:--:--
Stockwatch Reports
…

News Reports / Basic Materials / LYB

LYBLyondellBasell Industries NV

NYSE · Basic Materials · Mkt cap $21.2B · Avg vol 3.66M

$66.27

-2.37 (-3.45%)

Quote as of November 2, 2026, 1:41 PM ET

News Impact Report · Published November 2, 2026, 9:45 AM ET

LYB: LyondellBasell Posts Q3 2026 Operating Loss of $332M as Margins Remain Under Pressure

Share

LyondellBasell Industries NV (LYB) | Price: $66.10 | Today's Change: -3.80%


What Happened

LyondellBasell Industries NV filed an 8-K with the SEC on October 30, 2026, disclosing its third-quarter 2026 financial results under Items 2.02, 8.01, and 9.01. The company reported revenues of $23.06 billion for Q3 FY2026, alongside an operating loss of $332 million — a significant deterioration at the operating level. Basic and diluted earnings per share both came in at -$1.89, underscoring that the operating weakness translated directly into a per-share loss for the quarter. The filing also reports a net income figure of $5.617 billion, though this diverges sharply from the operating loss, suggesting the net income figure reflects a significant non-operating or one-time item not further detailed in the structured XBRL data provided.


Why It Matters

For investors, the headline takeaway is stark: despite generating over $23 billion in revenues — a substantial top-line figure — LyondellBasell failed to convert that revenue into operating profit in Q3 2026. An operating loss of $332 million on revenues of that scale points to meaningful margin compression, likely reflecting persistent headwinds in petrochemical and refining spreads, elevated input costs, or restructuring-related charges. The negative EPS of -$1.89 per share will weigh on near-term sentiment. The stock's drop of 3.80% today reflects the market's immediate negative reaction to this disclosure. Investors will want clarity on whether the reported net income figure of $5.617 billion is attributable to an asset sale, tax benefit, or another non-recurring event — because operationally, the quarter was a loss-making one.


Analysis

The disconnect between a net income of $5.617 billion and an operating loss of $332 million is the defining feature of this quarter and demands scrutiny. Typically, such a divergence arises from large asset disposals, significant unrealized gains, or extraordinary tax items — none of which reflect the underlying health of the core chemicals and refining business. For a cyclical commodity company like LyondellBasell, operating income is the more telling metric of business performance, and a loss at that line is a concerning signal.

The top-line revenue of $23.06 billion suggests volumes are not collapsing, but the inability to generate positive operating income indicates that cost pressures — whether from feedstocks, energy, or operational restructuring — are outpacing pricing power. This is consistent with broader industry dynamics that have weighed on European and US petrochemical producers through much of 2025 and into 2026.

StockWatch initiated coverage on LYB in September 2026; readers interested in the fundamental investment thesis and valuation framework should refer to that existing research. What this quarterly filing adds to that picture is confirmation that the near-term operating environment remains difficult, and that execution on cost reduction and portfolio optimization will be critical watchpoints heading into Q4 2026 and the full-year 2027 outlook.

Key items to watch going forward:

  • Source of the $5.617B net income: clarification on whether this reflects a one-time gain (e.g., asset divestiture) and its sustainability
  • Margin trajectory: whether Q3's operating loss is a trough or whether further deterioration is possible in Q4
  • Cash generation and balance sheet: operating losses can erode liquidity; free cash flow and debt metrics will matter
  • Guidance or management commentary: any forward-looking statements provided in the associated earnings call

Disclaimer

This report is a news and informational summary based solely on publicly available SEC filing data and does not constitute investment advice, a solicitation, or an offer to buy or sell any security. No investment rating or price target is issued or implied herein. Investors should conduct their own due diligence and consult a qualified financial advisor before making investment decisions.

Existing Coverage

StockWatch has full coverage on LYB, published 2026-09-25. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-10-30. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/1489393/000148939326000067/lyb-20261029.htm

StockWatch initiated coverage · September 25, 2026

LYB: Chemical Cycle Recovery Hinges on Refining Margins and Olefins Restocking

Deep-cycle trough valuation on depressed earnings. At $58.66, LYB trades near the lower half of its 52-week range ($41.58–$83.94) with trailing EPS of $-0.83, reflecting a severe petrochemical downcycle. The $18.9B market cap on 323.04M shares implies the market is pricing trough mid-cycle earnings power of roughly $1.5–2.0B, well below the $4B+ normalized EBITDA the asset base has historically generated. Low beta, high short interest signal a contested recovery trade. A beta of 0.35

+13.0%

Read the full report →

+13.0%

Key Data

Last

$66.10

P&L ($)

$-2.61

P&L (%)

-3.80%

Day Range

$65.37 - $66.92

Volume

110.20K

Market Cap

$21.2B

Previous Close

$68.71

Open

$66.11

52 Week Range

$41.58 - $83.94

Shares Outstanding

323.24M

Public Float

257.86M

Average Volume

3.66M

As of November 2, 2026, 9:48 AM ET

Advertise here
Stockwatch Reports

Free stock market updates, top gainers & losers, and AI-generated stock analyses — updated daily. Real-time price movements, quotes, and coverage for German & U.S. stoc